| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 07/05/2001 | WO2001000654A3 Purification and stabilization of peptide and proteins in pharmaceutical agents |
| 07/05/2001 | DE19963235A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments |
| 07/05/2001 | CA2395249A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 07/05/2001 | CA2394644A1 Substituted piperazine derivatives,the preparation thereof and their useas medicaments |
| 07/04/2001 | EP1112743A1 Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antiviral agents containing both |
| 07/04/2001 | EP1112269A2 Hiv protease inhibitors |
| 07/04/2001 | EP1112252A1 Kappa agonist compounds and pharmaceutical formulations thereof |
| 07/04/2001 | EP0850236B1 Piperazino derivatives as neurokinin antagonists |
| 07/03/2001 | US6255326 Antiinflammatory agent; autoimmune diseases |
| 07/03/2001 | US6255307 Pyrazine compounds |
| 06/28/2001 | WO2001046200A1 Novel piperidine and piperazine derivatives |
| 06/28/2001 | WO2001046157A1 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii |
| 06/28/2001 | WO2001046155A1 Potassium channel inhibitors |
| 06/28/2001 | WO2001046146A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001010834A3 Antibacterial agents |
| 06/28/2001 | CA2394095A1 Novel piperidine and piperazine derivatives |
| 06/28/2001 | CA2393756A1 Potassium channel inhibitors |
| 06/28/2001 | CA2392873A1 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii |
| 06/27/2001 | EP1109787A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 06/27/2001 | EP0824518B1 (het)aryloxy-, -thio-, aminocrotonates, methods of preparing them and their use as insecticides and fungicides |
| 06/27/2001 | EP0733046B1 benzoyl guanidines, their production and their use in medicaments |
| 06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
| 06/27/2001 | CN1301255A Heterocyclically substituted amides, their production and their use |
| 06/26/2001 | US6251913 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 06/26/2001 | US6251903 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist |
| 06/26/2001 | US6251363 Diagnostic and therapeutic alkylenediamine compounds and process |
| 06/21/2001 | WO2001044223A1 Inhibitors of interleukin 5 gene expression |
| 06/21/2001 | WO2001044206A1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044205A2 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents |
| 06/21/2001 | CA2395290A1 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents |
| 06/21/2001 | CA2393027A1 Inhibitors of interleukin 5 gene expression |
| 06/20/2001 | EP1107960A1 Pyrazine compounds |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | EP0890176B1 Proton conductor in liquid form |
| 06/20/2001 | CN1300279A Modulators of protein tyrosine phosphatases |
| 06/20/2001 | CN1067419C Reactive dyestuffs their preparation and their use |
| 06/20/2001 | CN1067392C Stable crystalline tetrahydrofolic acid salts |
| 06/20/2001 | CN1067387C 1,2,3,4-tetrahydroquinoxalindione derivative |
| 06/19/2001 | CA2095444C Fused pyrazine derivatives |
| 06/14/2001 | WO2001042211A2 Detection of transmembrane potentials by optical methods |
| 06/14/2001 | WO2001005773A8 Conjugates of sodium channel blockers and methods of using the same |
| 06/14/2001 | WO2001005354A3 Improved process for the preparation of benzenesulfonylureas as oral hypoglycemic agents of the second generation |
| 06/14/2001 | CA2393562A1 Detection of transmembrane potentials by optical methods |
| 06/13/2001 | CN1067063C Substituted carboxylic acylaniline derivative and plant disease control agent contg. same as active component |
| 06/13/2001 | CN1067053C Process for preparing intermediate of derivatives of monocyclic beta-lactam antibiotics |
| 06/13/2001 | CN1067050C Method for prodn. of 3-alkoxy-2-substituted phenmethyl acid or ester thereof |
| 06/12/2001 | US6245871 Group 8-10 transition metal olefin polymerization catalysts |
| 06/12/2001 | US6245760 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/07/2001 | WO2001030749B1 Novel compounds |
| 06/06/2001 | EP1104428A1 Continuous process for the preparation of n-(phosphonomethyl) iminodiacetic acid |
| 06/06/2001 | EP0879058B1 Mixtures derived from grains of eugenia jambolana lamarck, preparation and use of said mixtures and some of their constituents as medicaments |
| 06/06/2001 | CN1298397A Method for producing high melting point crystals of phenoxypropionic acid derivative |
| 06/06/2001 | CN1066772C Quantitative conversion of indene to (1S,2R) indene oxide and (1S,2R)-indanpiol by combination of haloperoxidase bioconversion and chemical steps |
| 06/06/2001 | CN1066723C HIV protease inhibitor intermediate and its producing process |
| 06/06/2001 | CN1066718C Substituted aryloxy-alkyl diamines and its producing process and use |
| 06/05/2001 | US6242602 One pot synthesis of 5,10-dihydrophenazine compounds and 5,10-substituted dihydrophenazines |
| 06/05/2001 | US6242495 Compounds and compositions for delivering active agents |
| 06/05/2001 | US6242494 Angiogenesis inhibitors, antitumor agents, diabetic retinopathy, and antiinflammatory agents |
| 05/31/2001 | WO2001037826A1 Npyy5 antagonists |
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
| 05/31/2001 | US20010002398 (6S)- or 10 (6R,S)- tetrahydrofolic acid is crystallized in a polar medium with pH of 3.5 or greater and have a purity 98% |
| 05/30/2001 | EP1103549A1 Photoprotective cosmetic compositions containing aminoamidine derivatives and uses thereof |
| 05/30/2001 | EP1102750A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
| 05/30/2001 | EP0815106B1 3-aryluracils and intermediates for their preparation |
| 05/30/2001 | CN1066444C Nitrogenous derivs. for elemene and their use as anticancer drugs |
| 05/29/2001 | US6239154 Arylacetamides, agonists at kappa opioid receptors. |
| 05/29/2001 | CA2325783A1 Ultraviolet-protecting cosmetic compounds containing amino- amidine derivatives and uses |
| 05/25/2001 | WO2000077027A3 Serine protease inhibitors |
| 05/25/2001 | WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/23/2001 | EP1100801A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 05/23/2001 | EP1100498A1 Heterocyclic sulphonamide derivatives |
| 05/23/2001 | EP1100485A1 Substituted anilide compounds and methods |
| 05/23/2001 | DE10022361C1 Preparation of 2-ethyl-3-methyl-1,4-diazine, useful as aroma, e.g. in food, involves reacting pentan-2,3-dione and ethan-1,2-diamine in aliphatic diol or triol containing alkaline salt, and catalytic dehydrogenation |
| 05/23/2001 | CN1296477A Piperazine derivatives and process for the preparation thereof |
| 05/23/2001 | CN1066168C Enhancing the storage stability of organic phosphites and phosphonites |
| 05/22/2001 | US6235905 Process for preparing alkoxypyrazine derivatives |
| 05/22/2001 | US6235768 Osteoporosis; rheumatic disorders; antitumor agents |
| 05/22/2001 | US6233841 Dehydration plant |
| 05/22/2001 | CA2217006C Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
| 05/17/2001 | WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 05/17/2001 | WO2001005390A3 Method for treating chronic pain using mek inhibitors |
| 05/17/2001 | CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 05/16/2001 | EP1099744A2 Organic electroluminescent device |
| 05/16/2001 | EP1098897A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 05/16/2001 | EP1098889A1 Substituted piperazones and their therapeutic uses |
| 05/16/2001 | EP1098888A1 Piperazinone derivatives and their uses |
| 05/16/2001 | EP1098870A2 Nitric esters and nitrate salts of specific drugs |
| 05/16/2001 | EP0839136B1 BENZO[g]QUINOLINE DERIVATIVES |
| 05/16/2001 | CN1295558A Novel local anesthetic compounds and uses |
| 05/16/2001 | CN1295548A Novel tricyclic compound |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/16/2001 | CN1065744C Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
| 05/15/2001 | US6232342 Protease inhibitors |
| 05/15/2001 | US6232057 Achieving enhanced sensitivity and reduced fog using iodide ion releasing compound which can release the iodide ion rapidly. |
| 05/15/2001 | CA2238978C Retroviral protease inhibiting compounds |
| 05/10/2001 | WO2001032604A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | DE19953647A1 Wasserlösliche Monoazoverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Farbstoffe Water-soluble monoazo compounds, to processes for their preparation and their use as dyes |